Matice Biosciences on Harnessing Regenerative Species and AI for Medical Breakthroughs

Date:



Scientists at Matice Biosciences are using AI to study the regeneration of tissues in animals known as super-regenerators, such as salamanders and planarians.

The goal of the research is to develop new treatments that will help humans heal from injuries without scarring.

On the latest episode of NVIDIA’s AI Podcast, host Noah Kravtiz spoke with Jessica Whited, a regenerative biologist at Harvard University and co-founder of Matice Biosciences.

Whited was inspired to start the company after her son suffered a severe injury while riding his bike.

She realized that while her work had been dedicated ultimately to limb regeneration, the short-term byproduct of it was a wealth of information that could be used to harness this regenerative science into topical treatments that can be put in the hands of everyday people, like her son and many others, who would no longer have to live with the physical scars of their trauma.

This led her to investigate the connection between regeneration and scarring.

Whited and her team are using AI to analyze the molecular and cellular mechanisms that control regeneration and scarring in super-regenerators.

They believe that by understanding these mechanisms, they can develop new treatments to help humans heal from injuries without scarring.

Learn more about Matice at www.maticebio.com or on Instagram, Twitter, Facebook and LinkedIn.

You Might Also Like

Jules Anh Tuan Nguyen Explains How AI Lets Amputee Control Prosthetic Hand, Video Games

A postdoctoral researcher at the University of Minnesota discusses his efforts to allow amputees to control their prosthetic limb — right down to the finger motions — with their minds.

Overjet’s Ai Wardah Inam on Bringing AI to Dentistry

Overjet, a member of NVIDIA Inception, is moving fast to bring AI to dentists’ offices. Dr. Wardah Inam, CEO of the company, discusses using AI to improve patient care.

Immunai CTO and Co-Founder Luis Voloch on Using Deep Learning to Develop New Drugs

Luis Voloch, co-founder and chief technology officer of Immunai, talks about tackling the challenges of the immune system with a machine learning and data science mindset.

Subscribe to the AI Podcast: Now Available on Amazon Music

The AI Podcast is now available through Amazon Music.

In addition, get the AI Podcast through iTunes, Google Podcasts, Google Play, Castbox, DoggCatcher, Overcast, PlayerFM, Pocket Casts, Podbay, PodBean, PodCruncher, PodKicker, Soundcloud, Spotify, Stitcher and TuneIn.

Make the AI Podcast better. Have a few minutes to spare? Fill out this listener survey.

Featured Image Credit: Matice Biosciences





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Which districts in Dubai are good for Remote work and for digital nomads?

Dubai offers several districts that are conducive to remote...

Bharat Mart and the Rise of a New Ecommerce Success Story in Dubai

In a significant stride towards strengthening trade ties between...

Top Loyalty Programs in Dubai

Dubai, the city of luxury and extravagance, knows a...

Navigating the Ivy League Journey: A Closer Look at HarvardMentoring.com

In the competitive landscape of college admissions, aspiring students...